Titel

Merkliste
1 Ergebnisse

Lanreotide as maintenance therapy after first-line treatmen..:

Lepage, Côme ; Phelip, J-M ; Lièvre, Astrid...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.07.033. , 2022

Link: https://hal.science/hal-03810530

RT Journal
T1 <Title>Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivbourgogne:oai:HAL:hal-03810530v1&Exemplar=1&LAN=DE
				
A1 Lepage, Côme
A1 Phelip, J-M
A1 Lièvre, Astrid
A1 Le Malicot, Karine
A1 Dahan, L
A1 Tougeron, David
A1 Toumpanakis, C
A1 Di Fiore, Frédéric
A1 Lombard-Bohas, C
A1 Borbath, I
A1 Coriat, R
A1 Lecomte, T
A1 Guimbaud, R
A1 Petorin, C
A1 Legoux, J.-L
A1 Michel, Pierre
A1 Scoazec, J.-Y
A1 Smith, D
A1 Walter, Thomas
PB HAL CCSD; Elsevier
YR 2022
K1 Clinical trial
K1 Duodeno-pancreatic
K1 Maintenance
K1 Neuroendocrine tumours
K1 Non-resectable
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.07.033
LK http://dx.doi.org/https://hal.science/hal-03810530
DO https://hal.science/hal-03810530
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)